Real-Life Effectiveness of Omalizumab in Severe Allergic Asthma Above the Recommended Dosing Range Criteria

Pediatrics - United States
doi 10.1542/peds.2017-2475kkkk
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Academy of Pediatrics (AAP)

Related search

P170 Long-Term Effectiveness of Omalizumab in Patients With Severe Persistent Allergic (IgE-mediated) Asthma: UK Centre Real-Life Experience

Thorax
PulmonaryRespiratory Medicine
2013English

Lengthening Omalizumab Dosing Interval in Treatment of Moderate to Severe Persistent Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Long-Term Effectiveness of Omalizumab Treatment in Thai Severe Asthmatic Patients: A Real-Life Experience

Asian Pacific Journal of Allergy and Immunology
MedicineAllergyImmunology
2017English

Omalizumab in the Treatment of Severe Allergic (IgE-mediated) Asthma: An Update on Recent Developments

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2013English

Cost- Effectiveness of Real Life Asthma Pharmacotherapy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Loss of Asthma Control After Cessation of Omalizumab Treatment: Real Life Data

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2014English

Effect of Omalizumab on Lung Function and Eosinophil Levels in Adolescents With Moderate-To-Severe Allergic Asthma

Annals of Allergy, Asthma and Immunology
Respiratory MedicinePulmonaryAllergyImmunology
2020English

Omalizumab Gets Tolerance in Patients With Severe Food Allergy: A Real-Life Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Effects of Omalizumab on Blood Eosinophil Numbers in Patients With Allergic Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy